Cyclerion Therapeutics, Inc. Share Price
NASDAQ: CYCN | Micro CapCyclerion Therapeutics, Inc. Stock Performance
Open $3.70 | Prev. Close $3.67 | Circuit Range N/A |
Day Range $3.63 - $3.72 | Year Range $1.04 - $8.39 | Volume 440 |
Average Traded $3.69 |
Cyclerion Therapeutics, Inc. Share Price Today
As of 11 August 2026, Cyclerion Therapeutics, Inc.'s share price is $3.72. The stock opened at $3.70, compared to its previous close of $3.67. During today's trading session, Cyclerion Therapeutics, Inc.'s share price traded between $3.63 and $3.72, with an average price of $3.67. Over the past 52 weeks, the stock has recorded a high of $8.39 and a low of $1.04. In terms of performance, Cyclerion Therapeutics, Inc.'s share price has risen by 175.56% over the last six months and is up 39.85% on a year-on-year basis.
Cyclerion Therapeutics, Inc. Share Price Chart
Cyclerion Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $11.83M | PE Ratio (TTM) -3.35 | Dividend Yield N/A |
EPS (TTM) $-1.11 | Revenue (TTM) $2.07M | Return On Equity (TTM) -38.83% |
Profit Margin -170.11% | Debt to Equity 0.10 | Quarterly Earnings Growth YoY -34.99% |
Cyclerion Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Cyclerion Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Cyclerion Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.51 | $3.67 | +7.00% |
Jul 2026 | $3.48 | $3.43 | +1.63% |
Jun 2026 | $3.15 | $3.38 | +7.14% |
May 2026 | $3.26 | $3.15 | -3.96% |
Apr 2026 | $5.42 | $3.28 | +121.62% |
Mar 2026 | $1.41 | $1.48 | +9.63% |
Feb 2026 | $1.38 | $1.35 | -4.59% |
Jan 2026 | $1.30 | $1.42 | +12.30% |
Dec 2025 | $1.53 | $1.26 | -20.25% |
Nov 2025 | $1.81 | $1.58 | -15.51% |
Oct 2025 | $2.25 | $1.87 | -18.34% |
Sep 2025 | $2.34 | $2.29 | -13.91% |
CYCN Share Price FAQs
What is Cyclerion Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Cyclerion Therapeutics, Inc. stock?
What is CYCN's market capitalisation today?
What is CYCN's net income for the last quarter?
What is the 5 year returns of CYCN?
What is the high & low stock price of CYCN today?
Can I buy CYCN shares in India?